Abstract
In this chapter, we continue to explore the many steps involved in percutaneous penetration, the laboratory techniques providing the background for this knowledge, and the insights advancing our knowledge of chemical exposure risk assessment, exposure prevention and barrier methods, and postexposure decontamination. We address knowledge gaps to guide future research to guide our ability to minimize the harmful effects of hazardous dermal chemical exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asbill CS, Michniak BB. Percutaneous penetration enhancers: Local versus transdermal activity. Pharm Sci Technol Today. 2000;3:36–41.
Barry BW. Structure, function, diseases, and topical treatment of human skin. In: Barry BW, editor. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 1983. p. 1–48.
Benson HAE. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2:23–33.
Braue EH, Doxzon BF, Lumpkin HL, Hanssen KA, Stevenson RS, Deckert RR, Graham JS. Military perspectives in chemical penetration retardation. In: Smith EW, Maibach H, editors. Percutaneous penetration enhancers. 2nd ed: Taylor & Francis Group, LLC; 2006. p. 385–97.
Bronaugh RL, Congdon ER. Percutaneous absorption of hair dyes: correlation with partition coefficients. J Invest Dermatol. 1984;83:124–7.
Bucks DW, Wester RC, Mobayen MM, Yang D, Maibach HI, Coleman D. In vitro percutaneous absorption and stratum corneum binding of alachlor: effect of formulation dilution with water. Toxicol Appl Pharmacol. 1989;100:417–23.
Chadrasekaran SK, Campbell PS, Watanabe T. Application of the ‘dual sorption’ model to drug transport through skin. Polym Eng Sci. 1980;20(1):36–9.
Chan HP, Zhai H, Hui X, Maibach H. Skin decontamination: principles and practices. Toxicol Ind Health. Published online Jul 30, 2012. https://doi.org/10.1177/0748233712448112.
Chattaraj SC, Walker RB. Penetration enhancer classification. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. Florida: CRC Press; 1995. p. 5–20.
Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol. 1983;80:44S–9S.
Federal Working Group on Pest Management. Occupational exposure to Pesticides – Report to the Federal Working Group on Pest Management from the Task Group on Occupational Exposure to Pesticides. Washington, D.C.; 1974
Franklin SF, Geffner ME. Precocious puberty secondary to topical testosterone exposure. J Pediatr Endocr Metab. 2003;16:107–10.
Gogoleva TE, Ademola JI, Wester RC, Magee PS, Maibach HI. Relative contributions of human skin layers to partitioning of chemicals with varying lipophilicity. In: Bronaugh R, Maibach HI, editors. Percutaneous absorption- drugs- cosmetics- mechanism- methodology. 3rd ed. New York; Chapter 26,: Marcel Dekker; 1999. p. 451–62.
Hadgraft J, Peck J, Williams DG, Pugh WJ, Allan G. Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Int J Pharm. 1996;141:17–25.
Hui X, Wester RC, Magee P, Maibach HI. Partitioning of chemicals from water into powdered human stratum corneum (callus): a model study. Vitro Toxicol. 1995;8(2):159–67.
Hui X, Wester RC, Zhai H, Cashmore AK, Barbadillo S, Maibach HI. Chemical partitioning into powdered human stratum corneum: a useful in vitro model for studying interactions of chemicals and human skin. In: Zhai H, Wilhelm KP, Maibach HI, editors. Marzulli and Maibach’s dermatotoxicology. 7th ed. Boca Raton: CRC Press, Taylor and Francis Group; 2008. p. 87–94.
Idson B. Vehicle effects in percutaneous absorption. Drug Metab Rev. 1983;14(2):207–22.
Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev. 2001;48:159–72.
Kintz P, Tracqui A, Morgin P. Accidental death caused by the absorption of 2, 4-dichlorophenol through the skin. Arch Toxicol. 1992;66:298–9.
McMaster J, Maibach HI, Wester RC, Bucks DAW. Dose rubbing enhance in vivo dermal absorption? In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption, mechanisms – methodology – drug delivery. New York/Basel: Marcel Dekker, Inc; 1985. p. 359–61.
Moody RP, Maibach HI. Skin decontamination: importance of the wash-in effect. Food Chem Toxicol. 2006;44(11):1783–8.
Noonan PK, Wester RC. Cutaneous metabolism of xenobiotics. In: Bronaugh RL, Maibach HI, editors. Percutaneous Absorption. New York: Marcel Dekker; 1989. p. 53–75.
Purdon CH, Smith EW, Surber C, Pellanda C. Assessment of vehicle effects by skin stripping. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. 2nd ed. Florida: CRC Press; 2005. p. 299–309.
Quan D, Hui X, Maibach HI. Chemical enhancements of transdermal drug delivery systems: advantages and challenges—Part 1. TransDermal. 2010a;(March):5–10.
Quan D, Hui X, Maibach HI. Chemical enhancements of transdermal drug delivery systems: advantages and challenges—Part 2. TransDermal. 2010b;(May):15–20.
Raykar PV, Fung MC, Anderson BD. The role of protein and lipid domains in the uptake of solutes of human stratum corneum. Pharm Res. 1988;5(3):140–50.
Ross JH, Driver JH, Harris SA, Maibach HI. Dermal absorption of 2,4-D: a review of species differences. Regul Toxicol Pharmacol. 2005;41:82–91.
Rougier A, Dupuis D, Lotte C, Roguet R, Wester RC, Maibach HI. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res. 1986;278:465–9.
Rougier A, Lotte C, Maibach HI. The hairless rat: a relevant animal model to predict in vivo percutaneous absorption in human? J Invest Dermatol. 1987a;88:577–81.
Rougier A, Lotte C, Maibach HI. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J Pharm Sci. 1987b;76(6):451–545.
Rougier A, Rallis M, Krien P, Lotte C. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res. 1990;282:498–505.
Schalla W, Jamoulle J, Schaefer H. Localization of compounds in different skin layers and its use as an indicator of percutaneous absorption. In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption. New York: Marcel Dekker; 1989. p. 283–312.
Scheuplein RJ, Blank IH. Mechanisms in percutaneous absorption. IV. Penetration of non-electrolytes (alcohols) from aqueous solutions and from pure liquids. J InvestDermatol. 1973;60(5):286–96.
Songkro S. An overview of skin penetration enhancers: penetration enhancing activity, skin irritation potential and mechanism of action. Songklanakarin J Sci Technol. 2009;31(3):299–321.
Surber C, Wilhelm KP, Hori M, Maibach HI, Guy RH. Optimization of topical therapy: partitioning of drug into stratum corneum. Pharm Res. 1990a;7(12):1320–4.
Surber C, Wilhelm KP, Hori M, Maibach HI, Guy RH. Partitioning of chemicals into human stratum corneum: implications for risk assessment following dermal exposure. Fundam Appl Toxicol. 1990b;15:99–107.
Wester RC, Maibach HI. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab Rev. 1983;14(2):169–205.
Wester RC, Bucks DW, Maibach HI, Anderson J. Polychlorinated biphenyls (PCBs): dermal absorption, systemic elimination, and dermal wash efficiency. J Toxicol Environ Health. 1983;12:511–9.
Wester RC, Mobayen M, Maibach HI. In vivo and in vitro absorption and binding to powdered stratum corneum as methods to evaluate skin absorption of environmental chemical contaminants from ground and surface water. J Toxicol Environ Health. 1987;21:367–74.
Wester RC, Maibach HI, Bucks D, McMaster J, Mobayen M, Sarason R, Moore RP. Percutaneous absorption and skin decontamination of PCBs: in vitro studies with human skin and in vivo studies in the rhesus monkey. J Toxicol Environ Health. 1990;31:235–46.
Wester RC, Melendres J, Sarason R, McMaster J, Maibach HI. Glyphosate skin binding, absorption, residual tissue distribution, and skin decontamination. Fundam Appl Toxicol. 1991;16(4):725–32.
Wester RC, Maibach HI, Sedik L, Melendres J. Percutaneous absorption of PCBs from soil: In vivo rhesus monkey, in vitro human skin, and binding to powdered human stratum corneum. J Toxicol Environ Health. 1993;39(3):375–82.
Wester RC, Melendres J, Logan F, Hui X, Maibach HI. Percutaneous absorption of 2,4-dichlorophenoxyacetic acid from soil with respect to soil load and skin contact time: In vivo absorption in rhesus monkey and in vitro absorption in human skin. J Toxicol Environ Health. 1996;47:335–44.
Wester RC, Melendres J, Sedik L, Maibach HI, Riviere J. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexyl phthalic acid and p-Aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol Appl Pharmacol. 1998;151:19–165.
Wester RC, Maibach HI, Hui X, Tanojo H. Progress Report of Environmental Management Science Program (DOE grant #DE-FG07-97ER62509): Bioavailability of organic solvents in soils: input into biologically-based dose-response models for human risk assessment; 1999.
Wester RC, Hui X, Maibach HI. In vivo human transfer of topical bioactive drug between individuals: estradiol. J Investig Dermatol. 2006;126:2190–3.
Yerasi AB, Butts JD, Butts JD. Disposal of used fentanyl patches. Am J Health Syst Pharm. 1997;54:85–6.
Zhai H, Maibach HI. Effect of barrier creams: human skin in vivo. Contact Dermatitis. 1996;35(2):92–6.
Zhai H, Maibach HI. Barrier creams – skin protectants: can you protect skin? J Cosmet Dermatol. 2002;1(1):20–3.
Zhai H, Chan HP, Hui X, Maibach HI. Skin decontamination of glyphosate from human skin in vitro. Food Chem Toxicol. 2008;46:2258–60.
Acknowledgments
This publication was supported by the Skin Disease Research Foundation––The San Francisco Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hui, X., Maibach, H.I. (2020). Isolated Human and Animal Stratum Corneum as a Partial Model for the 15 Steps of Percutaneous Absorption: Emphasizing Decontamination Part II. In: Zhu, H., Maibach, H. (eds) Skin Decontamination. Springer, Cham. https://doi.org/10.1007/978-3-030-24009-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-24009-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24008-0
Online ISBN: 978-3-030-24009-7
eBook Packages: MedicineMedicine (R0)